Defining hereditary alpha-tryptasemia as a risk/modifying factor for anaphylaxis: are we there yet?

Couto, M L; Silva, M; Barbosa, M J; Ferreira, F; Fragoso, A S; Azenha Rama, T

Couto, M L; Silva, M; Barbosa, M J; Ferreira, F; Fragoso, A S; Azenha Rama, T.

Afiliação

Couto ML; Basic and Clinical Immunology Service, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.
Silva M; Basic and Clinical Immunology Service, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.
Barbosa MJ; Basic and Clinical Immunology Service, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.
Ferreira F; Basic and Clinical Immunology Service, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.
Fragoso AS; Basic and Clinical Immunology Service, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.
Azenha Rama T; Basic and Clinical Immunology Service, Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.

Eur Ann Allergy Clin Immunol ; 55(4): 152-160, 2023 07.

Article em En | MEDLINE | ID: mdl-36927821

Assuntos

Anafilaxia; Síndrome da Ativação de Mastócitos; Mastocitose; Humanos; Anafilaxia/diagnóstico; Anafilaxia/genética; Mastócitos; Mastocitose/diagnóstico; Fatores de Risco; Triptases/genética

Palavras-chave

Anaphylaxis; hereditary alpha-tryptasemia syndrome; mast cell activation syndrome; serum baseline tryptase; tryptase

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mastocitose / Síndrome da Ativação de Mastócitos / Anafilaxia Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Ann Allergy Clin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Portugal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google